Document is current
Any future updates will be listed below
-
Authors
Sasaguri, Hiroki https://orcid.org/0000-0003-2550-9156
Nilsson, Per https://orcid.org/0000-0001-6450-0870
Hashimoto, Shoko https://orcid.org/0000-0002-5778-4884
Nagata, Kenichi https://orcid.org/0000-0001-8377-7197
Saito, Takashi https://orcid.org/0000-0002-9659-9251
De Strooper, Bart https://orcid.org/0000-0001-5455-5819
Hardy, John https://orcid.org/0000-0002-3122-0423
Vassar, Robert
Winblad, Bengt https://orcid.org/0000-0002-0011-1179
Saido, Takaomi C https://orcid.org/0000-0003-1970-6903
-
Funding
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science, and Technology (26290019)
Ministry of Education, Culture, Sports, Science, and Technology (15K19036)
RIKEN
Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (JPMJPR1285)
Strategic Research Program for Brain Sciences (17dm0107071h0002)
Japan Agency for Medical Research and Development
Alzheimerfonden
Hållstens forskningsstiftelse
Svenska Forskningsrådet Formas
HHS | National Institutes of Health (AG022560)
HHS | National Institutes of Health (AG030142)
- License Information
-
More Information
Article History
Received: 19 May 2017
Revised: 9 June 2017
Accepted: 7 July 2017
First Online: 2 August 2017
Conflict of interest
: TCS and TS serve as the CEO and advisor, respectively, for RIKEN BIO Co. Ltd., which sublicenses animal models to for‐profit organizations, the profits from which are used for the identification of disease biomarkers.
